Introduction: Serious or uncontrolled activation of myeloid cells like monocytes, macrophages and dendritic cells (DCs) is a trademark of immune-mediated inflammatory Diseases. There may be an urgent need for the event of novel medication With all the potential to impair innate immune cell overactivation underneath inflammatory situations. Powerful evidence identified https://win55.clinic/ban-ca